Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 11, Issue 3, 2002, Pages 176-182

  Dilley, A ^a   Benito, C ^b   Hooper, W C ^a   Austin, H ^a,c   Miller, C ^a   El Jamil, M ^a,c   Cottrell, S ^a   Benson, J ^a   Evatt, B L ^a   Patterson Barnett, A ^d   Eller, D ^d   Philipp, C ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

^d Northside Women's Specialists   (United States)

Author keywords

Factor V Leiden; Fetal loss; MTHFR; Prothrombin G20210A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; OXIDOREDUCTASE; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; SPONTANEOUS ABORTION; UNITED STATES; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; PREGNANCY; RISK; RISK FACTOR; STATISTICAL MODEL;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MUTATION; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREGNANCY; PROTEIN C; PROTEIN S; PROTHROMBIN; RISK FACTORS;

EID: 0036021465     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.11.3.176.182     Document Type: Article

References (43)

1. Recurrent pregnancy loss: A review
2. Recurrent miscarriage [see comments] I: Definition and epidemiology
3. Frequency of factors associated with habitual abortion in 197 couples
4. Recurrent pregnancy loss. An update
5. Recurrent miscarriage: Causes, evaluation, and treatment
6. Recurrent pregnancy loss: An update
7. Pregnancy loss in the antiphospholipid syndrome - A possible thrombogenic mechanism
8. Maternal hemostasis: Coagulation problems of pregnancy
9. Increased fetal loss in women with heritable thrombophilia
10. Increased frequency of genetic thrombophilia in women with complications of pregnancy
11. Activated protein C resistance caused by Arg506Gln mutation in factor Va
12. Mutation in blood coagulation factor V associated with resistance to activated protein C
13. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia study
14. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis
15. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations
16. Genetic factors associated with thrombosis in pregnancy in a United States population
17. Fetal carriers of the FV Leiden mutation are prone to miscarriage and placental infarction
18. FV Leiden mutation as a risk factor for recurrent pregnancy loss
19. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss
20. Is FV Leiden a risk factor for recurrent fetal loss?
21. The FV Leiden mutation is not a common cause of recurrent miscarriage
22. FV Leiden is associated with repeated and recurrent unexplained fetal losses
23. Mutations in coagulation factors in women with unexplained late fetal loss
24. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
25. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden)
26. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (FV Leiden)
27. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
28. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene
29. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause
30. FV Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages
31. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
32. Prevalence of moderate hyperhomocysteinema in patients with early-onset venous and arterial occlusive disease
33. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
34. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss
35. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss
36. Prospective evaluation of the risk conferred by FV Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy
37. Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss
38. Hereditary thrombophilia as a cause of fetal loss
39. An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio
40. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - A possible evolutionary mechanism
41. Activated protein C resistance (FV:Q506) and pregnancy
42. Estimates of human fertility and pregnancy loss
43. Activated protein C resistance and factor V Leiden mutation can be associated with first as well as second-trimester recurrent pregnancy loss